Dates as a Functional Food for Autism
NCT04261595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2022-06-03
Summary
Autism spectrum disorder (ASD) is a lifelong developmental disability that includes deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests, or activities.
The current treatment approaches for the management of autism are expensive, showing unwanted adverse effects; alter the genetic and metabolic pathways. Many studies referred to the importance of probiotics, minerals and antioxidant supplementation in the treatment of accompanied eating and feeding problems. Meanwhile, there are still controversial results about the effectiveness of dietary interventions for ASD like the gluten-free/casein-free diet and the ketogenic diet.
Dates have been documented in the Holy Quran and proved in modern scientific literature to act as potent antioxidants and as an anti-inflammatory, provide a suitable alternative therapy in various diseases cure.
The medicinal therapeutic value of date fruits as nutritional probiotic and its implications in controlling autism through the anti-oxidant effect will be evaluated. Moreover, at which dose Dates fruit can exert its effect and whether this effect is sustained or not will be also evaluated. Besides, Dates' effect on cognitive, neurological parameters, eating behaviors, and gastrointestinal symptoms and anthropometric measures will be evaluated. A non-randomized clinical study on 120 diagnosed autistic children aged 3-12 years in Cairo will be conducted. Participants will be randomly assigned to one of three groups (each with 40 children) receiving one of three regimens; the first group will receive 3 Dates per day for 3 months and the second group will receive 5 Dates per day for 3 months and the third group will receive nothing. All groups will receive nutrition guidance, behavioral modification, and stimulation sessions. Stools and blood samples will be collected before the study, after 12 weeks of the intervention and then 12 weeks after completion of the intervention. Evaluating Dates' ability to decrease the oxidative stress will be done through comparing blood levels of three oxidative markers; Malondialdehyde (MDA), glutathione peroxidase (GPX1) and superoxide dismutase (SOD) in children with autism for the three proposed regimen. The impact of the Dates fruit consumption on the microbiota of the autistic children both the pathogenic bacteria and probiotics will be done through traditional stool analysis and Real-time PCR before and after interventions.
Conditions
- Autistic Spectrum Disorder
Interventions
- OTHER
-
Dates fruit as functional Food
Two groups will receive Dates; The number per group is dependant on the child age. For children aged 3-6 years; they will receive the minimum numbers of dates (3 pieces). For children aged more than 6-12 years will receive 5 pieces of Dates the choice of the minimum numbers of dates (3 pieces) in this current trial is based on a study that was done by Al Jaouni and his colleagues, 2019 which proved the effects of three pieces of Ajwa on infection, hospitalization, and survival among 26 pediatric cancer patients in a university hospital; for which their treatment outcome was improved due to their intake of this amount of Ajwa during their standard treatment
- BEHAVIORAL
-
behavioral modification and stimulation
Behavioral modification applied to the autistic children that is based on applied behavior analysis (ABA), a widely accepted approach that tracks a child's progress in improving his or her skills. We use Positive Behavioral and Support (PBS)
- OTHER
-
nutritional Guidance
The nutritional education sessions are based on educating parents on providing their autistic children with a nutritious, balanced diet. Because children with ASD often have restricted diets as well as difficulty sitting through meal times, they may not be getting all the nutrients they need, particularly calcium and protein
Sponsors & Collaborators
-
National Research Centre, Egypt
lead OTHER
Principal Investigators
-
Ammal M Metwally, PhD · National Research Centre, Egypt
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-15
- Primary Completion
- 2022-01-15
- Completion
- 2022-04-15
Countries
- Egypt
Study Locations
More Related Trials
-
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
NCT02561481 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Food Selectivity Protocol for Children With Autism Spectrum Disorders
NCT06179940 ·Status: RECRUITING ·Phase: NA
-
Efficiency of Bumetanide in Autistic Children
NCT01078714 ·Status: COMPLETED ·Phase: PHASE3
-
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
NCT02677051 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Sulforaphane-rich Broccoli Sprout Extract for Autism
NCT01474993 ·Status: COMPLETED ·Phase: PHASE2
-
Dietetic Pattern in Children With Autism Spectrum Disorders
NCT04719923 ·Status: COMPLETED
-
AUT-MENU: Improving Meal Experience of Subjects With Autism Spectrum Disorder
NCT06266377 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Modified Dental Visual Aids on Behavior Management During Dental Treatment in Children With Autism Spectrum Disorder
NCT04576559 ·Status: COMPLETED ·Phase: NA
-
Parent-implemented Social Communication Treatment in Autism
NCT05635760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Training Programme to Reduce Stress
NCT02384486 ·Status: COMPLETED ·Phase: NA
-
Mercury Chelation to Treat Autism
NCT00376194 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
NCT03195465 ·Status: TERMINATED ·Phase: NA
-
Efficacy Evaluation and Mechanism Study of Ketogenic Diet on Autism Spectrum Disorder in Children
NCT06348433 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Nutritional and Dietary Treatment Study for Children/Adults With Autism
NCT02059577 ·Status: COMPLETED ·Phase: PHASE2
-
Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
NCT03434366 ·Status: SUSPENDED ·Phase: PHASE2
-
Gut Microbiota Diversity: Wrong Message in Autism, Wrong Architecture in Formation
NCT06662916 ·Status: COMPLETED
-
Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
NCT02094651 ·Status: WITHDRAWN ·Phase: PHASE2
-
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
NCT03757585 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
NCT00453180 ·Status: COMPLETED ·Phase: PHASE2
-
Galantamine Versus Placebo in Childhood Autism
NCT00252603 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
NCT03963479 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Feeding Problems in Children With Autism
NCT02275715 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D Therapy in Autism Spectrum Disorder
NCT05595044 ·Status: UNKNOWN ·Phase: PHASE1
-
Parent Language Intervention for Autism
NCT02632773 ·Status: COMPLETED ·Phase: NA
-
Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder
NCT00873509 ·Status: COMPLETED ·Phase: PHASE2/PHASE3